LABCORP HOLDINGS INC. (LH) Gross Margin
- Gross margin · 12 months: Value 28.88%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 28.88% | Gross profit / revenue. Period ending 2026-06-30. $4.14B ÷ $14.35B × 100 ≈ 28.88% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 4.14B USD | Gross Profit |
| Revenue | 14.35B USD | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $4.14B | $14.35B | (m) | 28.88% |
| 2026-03-31 | $4.08B | $14.14B | (m) | 28.83% |
| 2025-12-31 | $4.01B | $13.95B | (m) | 28.76% |
| 2025-09-30 | $3.92B | $13.77B | (m) | 28.45% |
| 2025-06-30 | $3.79B | $13.48B | (m) | 28.14% |
| 2025-03-31 | $3.68B | $13.18B | (m) | 27.89% |
| 2024-12-31 | $3.62B | $13.01B | (m) | 27.86% |
| 2024-09-30 | $3.55B | $12.71B | (m) | 27.92% |
| 2024-06-30 | $3.50B | $12.49B | (m) | 28.00% |
| 2024-03-31 | $3.41B | $12.30B | (m) | 27.74% |
| 2023-12-31 | $3.36B | $12.16B | (m) | 27.67% |
| 2023-09-30 | $4.02B | $15.07B | (m) | 26.66% |
| 2023-06-30 | $4.05B | $14.88B | (m) | 27.24% |
| 2023-03-31 | $4.13B | $14.76B | (m) | 27.97% |
| 2022-12-31 | $4.39B | $14.88B | (m) | 29.48% |
| 2022-09-30 | $4.79B | $15.26B | (m) | 31.39% |
| 2022-06-30 | $5.12B | $15.72B | (m) | 32.56% |
| 2022-03-31 | $5.26B | $15.86B | (m) | 33.16% |
| 2021-12-31 | $5.62B | $16.12B | (m) | 34.89% |
| 2021-09-30 | $6.15B | $16.55B | (m) | 37.18% |
| 2021-06-30 | $6.33B | $16.39B | (m) | 38.61% |
| 2021-03-31 | $5.82B | $15.32B | (m) | 38.02% |
| 2020-12-31 | $4.95B | $13.98B | (m) | 35.43% |
| 2020-09-30 | $3.87B | $12.44B | (m) | 31.09% |
| 2020-06-30 | $3.13B | $11.47B | (m) | 27.25% |
| 2020-03-31 | $3.19B | $11.59B | (m) | 27.54% |
| 2019-12-31 | $3.25B | $11.55B | (m) | 28.15% |
| 2019-09-30 | $3.20B | $11.39B | (m) | 28.13% |
| 2019-06-30 | $3.18B | $11.29B | (m) | 28.13% |
| 2019-03-31 | $3.19B | $11.28B | (m) | 28.26% |
| 2018-12-31 | $3.18B | $11.33B | (m) | 28.03% |
| 2018-09-30 | $3.59B | (m) | (m) | (m) |
| 2018-06-30 | $3.59B | (m) | (m) | (m) |
| 2018-03-31 | $3.53B | (m) | (m) | (m) |
| 2017-12-31 | $3.46B | (m) | $6.74B | (m) |
| 2017-09-30 | $3.34B | (m) | $6.56B | (m) |
| 2017-06-30 | $3.24B | (m) | $6.42B | (m) |
| 2017-03-31 | $3.21B | (m) | $6.34B | (m) |
| 2016-12-31 | $3.18B | (m) | $6.26B | (m) |
| 2016-09-30 | $3.13B | (m) | $6.16B | (m) |
| 2016-06-30 | $3.11B | (m) | $6.08B | (m) |
| 2016-03-31 | $3.06B | (m) | $5.97B | (m) |
| 2015-12-31 | $2.90B | (m) | $5.60B | (m) |
| 2015-09-30 | $2.71B | (m) | $5.06B | (m) |
| 2015-06-30 | $2.52B | (m) | $4.54B | (m) |
| 2015-03-31 | $2.28B | (m) | $4.07B | (m) |
| 2014-12-31 | $2.20B | $6.01B | $3.81B | 36.65% |
| 2014-09-30 | $2.18B | $5.94B | $3.75B | 36.77% |
| 2014-06-30 | $2.16B | $5.85B | $3.69B | 36.93% |
| 2014-03-31 | $2.17B | $5.80B | $3.63B | 37.39% |
| 2013-12-31 | $2.22B | $5.81B | $3.59B | 38.28% |
| 2013-09-30 | $2.24B | $5.78B | $3.54B | 38.69% |
| 2013-06-30 | $2.24B | $5.73B | $3.49B | 39.13% |
| 2013-03-31 | $2.25B | $5.69B | $3.44B | 39.48% |
| 2012-12-31 | $2.25B | $5.67B | $3.42B | 39.67% |
| 2012-09-30 | $2.26B | $5.63B | $3.37B | 40.15% |
| 2012-06-30 | $2.27B | $5.62B | $3.34B | 40.48% |
| 2012-03-31 | $2.28B | $5.60B | $3.31B | 40.78% |
| 2011-12-31 | $2.27B | $5.54B | $3.27B | 41.04% |
| 2011-09-30 | $2.25B | $5.47B | $3.22B | 41.21% |
| 2011-06-30 | $2.21B | $5.34B | $3.13B | 41.43% |
| 2011-03-31 | $2.16B | $5.18B | $3.02B | 41.70% |
| 2010-12-31 | $2.10B | $5.00B | $2.91B | 41.92% |
| 2010-09-30 | $2.04B | $4.87B | $2.83B | 41.94% |
| 2010-06-30 | $2.01B | $4.78B | $2.77B | 42.13% |
| 2010-03-31 | $1.99B | $4.73B | $2.74B | 42.01% |
| 2009-12-31 | $1.97B | $4.69B | $2.72B | 41.98% |
| 2009-09-30 | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) |
| 2008-12-31 | $1.87B | $4.51B | $2.63B | 41.59% |
| 2008-09-30 | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) |
| 2007-12-31 | $1.69B | $4.07B | $2.38B | 41.57% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |